The Skipton Fund is a UK-wide ex gratia payment scheme established on 25 March 2004 to make payments to certain people who were infected with hepatitis C through treatment with NHS blood or blood products prior to September 1991 and other persons eligible for payment in accordance with the scheme's provisions. The Skipton Fund was established by the Department of Health (England), acting for and on behalf of the Secretary of State for Health, the Scottish Ministers, the National Assembly for Wales and the Department of Health, Social Services and Public Safety (Northern Ireland) (together "the UK health administrations"), to administer the scheme and make payments to relevant claimants on behalf of each of the UK health administrations.
Scottish Ministers have adopted the Skipton Fund as a scheme under section 28 (Infection with hepatitis C as a result of NHS treatment etc) of the Smoking, Health and Social Care (Scotland) Act 2005.
A first stage payment of £20,000 is available to those who are eligible for payment under the scheme. For successful recipients of the first stage payment whose hepatitis C infection has led to advanced liver disease there is a second stage payment payable of £50,000.
Those who have received the Stage 2 payment are also entitled to additional annual payments of £14,574 per year, paid monthly or quarterly and index-linked to the Consumer Prices Index (with effect from 1 April each year).
If you feel you may be eligible for a payment please view the basic payment form and guidance notes by clicking here.
For more information please visit www.skiptonfund.org or call +44 (0) 20 7 808 1160